The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
Authors
Keywords
Diabetes, Endothelial progenitor cells, Saxagliptin, DPP-4 inhibitor, Arterial stiffness
Journal
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-03
DOI
10.1186/s12933-018-0709-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Kidney Injury and Progression of Diabetic Kidney Disease
- (2018) Samuel Mon-Wei Yu et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia
- (2018) Sherin Bakhashab et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
- (2017) Fang Li et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- The Correlation of Arterial Stiffness with Biophysical Parameters and Blood Biochemistry
- (2017) Anamil M. Khiyami et al. Metabolic Syndrome and Related Disorders
- Use of p53‐Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease
- (2017) Nabanita Kundu et al. Journal of the American Heart Association
- Metformin improves the angiogenic potential of human CD34+ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction
- (2016) Sherin Bakhashab et al. Cardiovascular Diabetology
- Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study
- (2016) Fahad W. Ahmed et al. Cardiovascular Diabetology
- 8. Pharmacologic Approaches to Glycemic Treatment
- (2016) DIABETES CARE
- Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
- (2016) Xin Liu et al. Lipids in Health and Disease
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus
- (2016) Lea Duvnjak et al. Diabetology & Metabolic Syndrome
- Chronic endurance exercise affects paracrine action of CD31+ and CD34+ cells on endothelial tube formation
- (2015) Rian Q. Landers-Ramos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients
- (2015) Colman Siu Cheung Fung et al. Cardiovascular Diabetology
- Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
- (2015) Feng Sun et al. CLINICAL THERAPEUTICS
- Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
- (2015) Mauro Rigato et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor
- (2015) Felicia Goldsmith et al. PLoS One
- Genetic modification of human mesenchymal stem cells helps to reduce adiposity and improve glucose tolerance in an obese diabetic mouse model
- (2015) Sabyasachi Sen et al. Stem Cell Research & Therapy
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: Stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?
- (2014) Tongzhi Wu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
- (2013) M. Afkarian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells
- (2012) Chun-Yao Huang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans
- (2012) G. P. Fadini et al. DIABETES CARE
- DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors
- (2011) D. Dicker DIABETES CARE
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice
- (2010) Eric J. Marrotte et al. JOURNAL OF CLINICAL INVESTIGATION
- Physical exercise induces expression of CD31 and facilitates neural function recovery in rats with focal cerebral infarction
- (2010) Xiquan Hu et al. NEUROLOGICAL RESEARCH
- SDF-1α involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice
- (2009) Yangguang Yin et al. CARDIOVASCULAR PATHOLOGY
- Saxagliptin
- (2009) Sohita Dhillon et al. DRUGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started